185 related articles for article (PubMed ID: 4403564)
1. Decarboxylation of 3,4-dihydroxyphenylalanine (DOPA) by erythrocytes: a reaction promoted by methemoglobin and other ferriheme proteins.
Tate SS; Orlando J; Meister A
Proc Natl Acad Sci U S A; 1972 Sep; 69(9):2505-8. PubMed ID: 4403564
[TBL] [Abstract][Full Text] [Related]
2. Decarboxylation of 3,4-dihydroxyphenylalanine by oxyhemoglobin.
Yamabe H; Lovenberg W
Biochem Biophys Res Commun; 1972 May; 47(4):733-9. PubMed ID: 5063594
[No Abstract] [Full Text] [Related]
3. Decarboxylation of radioactive DOPA by erythrocytes in schizophrenia.
Tran N; Laplante M; Lebel E
Br J Psychiatry; 1971 Apr; 118(545):465-6. PubMed ID: 5576648
[No Abstract] [Full Text] [Related]
4. An enzymic reduction system for metmyoglobin and methemoglobin, and its application to functional studies of oxygen carriers.
Hayashi A; Suzuki T; Shin M
Biochim Biophys Acta; 1973 Jun; 310(2):309-16. PubMed ID: 4146292
[No Abstract] [Full Text] [Related]
5. Metabolism of tryptophan in the liver: interference with decarboxylation of other aromatic amino acids.
Drsata J; Marklová E
Acta Medica (Hradec Kralove); 2000; 43(1):15-7. PubMed ID: 10934780
[TBL] [Abstract][Full Text] [Related]
6. Reactions of DOPA (3,4-dihydroxyphenylalanine) decarboxylase with DOPA.
Minelli A; Charteris AT; Voltattorni CB; John RA
Biochem J; 1979 Nov; 183(2):361-8. PubMed ID: 534502
[TBL] [Abstract][Full Text] [Related]
7. THE INFLUENCE OF PEROXIDASES ON THE DOPA-SYSTEM.
VAN DER PLOEG M; VAN DUIJN
J R Microsc Soc; 1964 Dec; 83():405-14. PubMed ID: 14319450
[No Abstract] [Full Text] [Related]
8. Intestinal decarboxylation of L-Dopa in relation to dose requirement in Parkinson's disease.
Granerus AK; Jagenburg R; Svanborg A
Naunyn Schmiedebergs Arch Pharmacol; 1973; 280(4):429-39. PubMed ID: 4274706
[No Abstract] [Full Text] [Related]
9. Decrease of the 3,4-dihydroxyphenylalanine (DOPA) decarboxylase activities in human erythrocytes and mouse tissues after administration of DOPA.
Tate SS; Sweet R; McDowell FH; Meister A
Proc Natl Acad Sci U S A; 1971 Sep; 68(9):2121-3. PubMed ID: 5289372
[TBL] [Abstract][Full Text] [Related]
10. Decarboxylation of DL-2,4-dihydroxyphenylalanine (2,4-DOPA) to 2,4-dihydroxyphenylethylamine in mouse striatal slices.
Orosz D; Cohen G
Eur J Pharmacol; 1987 Apr; 136(3):441-4. PubMed ID: 3111867
[TBL] [Abstract][Full Text] [Related]
11. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms.
Cumming P; Gjedde A
Synapse; 1998 May; 29(1):37-61. PubMed ID: 9552174
[TBL] [Abstract][Full Text] [Related]
12. The valence and spin state of iron in oxyhemoglobin as inferred from resonance Raman spectroscopy.
Yammoto T; Palmer G
J Biol Chem; 1973 Jul; 248(14):5211-3. PubMed ID: 4352197
[No Abstract] [Full Text] [Related]
13. Studies on the metabolism of D- and L-isomers of 3,4-dihydroxyphenylalanine (DOPA). VI. Metabolism of D-DOPA in rat kidney.
Shindo H; Maeda T
Chem Pharm Bull (Tokyo); 1974 Aug; 22(8):1721-31. PubMed ID: 4154147
[No Abstract] [Full Text] [Related]
14. alpha,beta-Dehydro-3,4-dihydroxyphenylalanine derivatives: potential schlerotization intermediates in natural composite materials.
Rzepecki LM; Nagafuchi T; Waite JH
Arch Biochem Biophys; 1991 Feb; 285(1):17-26. PubMed ID: 1846730
[TBL] [Abstract][Full Text] [Related]
15. Variations in aromatic amino acid decarboxylase activity towards DOPA and 5-hydroxytryptophan caused by pH changes and denaturation.
Bender DA; Coulson WF
J Neurochem; 1972 Dec; 19(12):2801-10. PubMed ID: 4652630
[No Abstract] [Full Text] [Related]
16. Inhibition of dopa decarboxylation by RO4-4602, MK 485 and MK 486 in human liver homogenates.
Vogel WH; Mahoney K; Hare TA
Arch Int Pharmacodyn Ther; 1972; 198(1):85-93. PubMed ID: 4538242
[No Abstract] [Full Text] [Related]
17. Reduction of extracellular methemoglobin by erythrocytes.
McGown EL; Lyons MF; Marini MA; Zegna A
Biochim Biophys Acta; 1990 Dec; 1036(3):202-6. PubMed ID: 2257276
[TBL] [Abstract][Full Text] [Related]
18. The enzymatic decarboxylation of DOPA in human liver homogenates.
Vogel WH; Snyder R; Hare TA
Proc Soc Exp Biol Med; 1970 Jun; 134(2):477-81. PubMed ID: 5310151
[No Abstract] [Full Text] [Related]
19. Antioxidant protein 2 prevents methemoglobin formation in erythrocyte hemolysates.
Stuhlmeier KM; Kao JJ; Wallbrandt P; Lindberg M; Hammarström B; Broell H; Paigen B
Eur J Biochem; 2003 Jan; 270(2):334-41. PubMed ID: 12605684
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte cytochrome b5; structure, role in methemoglobin reduction, and solubilization from endoplasmic reticulum.
Hultquist DE; Slaughter SR; Douglas RH; Sannes LJ; Sahagian GG
Prog Clin Biol Res; 1978; 21():199-216. PubMed ID: 275867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
